We could detect a significant degree of NFAT2 overexpression in CLL cells as compared to physiological B cells on the mRNA as well as on the protein level which was substantially more pronounced in the indolent patient cohort (Fig. 1a–c). Here, NFATC1 is linked to B-cell chronic lymphocytic leukemia.